Company / Cash per Share
Eledon Pharmaceuticals, Inc. Cash per Share History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.06
FY2016
5-year range
$1.06 / $23.70
FY2014-FY2016
Trend
-25.1%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $23.70 to $1.06 over the past 2 years.
Based on SEC 10-K filings.
1.06 in FY2016.
Declined from $23.70 to $1.06 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, cash per share decreased 25.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $1.06 | -25.1% |
| FY2015 | $1.42 | -94.0% |
| FY2014 | $23.70 | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026